Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 154 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.29Abortion, Habitual 34489969 Decreased USP2a Expression Inhibits Trophoblast Invasion and Associates With Recurrent Miscarriage. causal interaction
unassigned
3
0
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.29Adenocarcinoma 22585994 MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. causal interaction
diagnostic usage
therapeutic application
unassigned
4
3
3
0
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.29Adenocarcinoma 24071644 USP2a alters chemotherapeutic response by modulating redox. unassigned 0
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.29Adenocarcinoma of Lung 29490279 USP2a Supports Metastasis by Tuning TGF-? Signaling. causal interaction
ongoing research
therapeutic application
unassigned
4
2
4
0
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.29Breast Neoplasms 19838211 MdmX is a substrate for the deubiquitinating enzyme USP2a. therapeutic application
unassigned
2
0
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.29Carcinoma 19362044 Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas. causal interaction
diagnostic usage
ongoing research
therapeutic application
3
3
3
1
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.29Carcinoma, Embryonal 19838211 MdmX is a substrate for the deubiquitinating enzyme USP2a. therapeutic application
unassigned
2
0
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.29Carcinoma, Hepatocellular 33074477 Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A. therapeutic application
unassigned
1
0
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.29Cardiomyopathies 10086389 Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. causal interaction
unassigned
1
0
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.29Cardiomyopathies 11056105 Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy. causal interaction
therapeutic application
unassigned
4
2
0
Results 1 - 10 of 154 > >>